Lucknow, May 18: A memory enhancement drug, developed by the Lucknow-based Central Drug Research Institute (CDRI), a constituent laboratory of the Council of Scientific and Industrial Research (CSIR), was today launched in the market.
“The drug developed by the institute is being launched in the market in a capsule form under the brand name of ‘Memory Sure’ by Zaar distributors for medical use,” head of CDRI’s business management Rajendra Prasad told reporters here.
He said the drug contains a special bacosides enriched standardised extract of Bacopa Monniera, commonly known as ‘Brahmi’ (a herb), with an optimum concentration of bacogenins to produce the best cognitive enhancing effect.
“Bacopa Monniera is an important Ayurvedic plant used in India since the time of Vedic civilisation,” he said.
He said clinical trials have demonstrated the efficacy of the drug is significantly revitalising intellectual functions and also attenuating Attention Deficit Hyperactivity Disorder (ADHD) in children.
–Agencies